Références
p. 73-75
Plan détaillé
Texte intégral
Des DOI sont automatiquement ajoutés aux références bibliographiques par Bilbo, l’outil d’annotation bibliographique d’OpenEdition. Ces références bibliographiques peuvent être téléchargées dans les formats APA, Chicago et MLA.
Format
- APA
- Chicago
- MLA
Administrator, “The scourge of fake medicine”, Bangkok Post, 14 February 2008, www.bangkokpost.com, Accessed Sep 2010.
Delacollette C., C. D’Souza, E. Christophel, K. Thimasarn, R. Abdur, D. Bell, TC. Dai, D. Gopinath, SH. Lu, R. Mendoza, L. Ortega, R. Rastogi, C. Tantinimitkul and J. Ehrenberg, “Malaria Trends and Challenges in the Greater Mekong Subregion”, Southeast Asian J Trop Med Public Health 40/4 (2009).
Dondorp AM., F. Nosten, P. Yi, D. Das, AP. Phyo, J. Tarning, KM. Lwin, F. Ariey, W. Hanpithakpong, SJ. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, SS. An, S. Yeung, P. Singhasivanon, NP. Day, N. Lindegardh, D. Socheat, NJ. White. “Artemisinin resistance in Plasmodium falciparum malaria”. N Engl J Med 361 (2009) pp. 455-67.
Eggleston, K., R. Zhang, and RJ. Zeckhauser, “The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis”, Int. J. Environ. Res. Pub. Health 7 (2010) pp. 3141-3149.
Noedl, H. et al., “Evidence of Artemisinin-Resistant Malaria in Western Cambodia”. N Engl J Med 359; 24 www.nejm.org December 11, 2008.
Laven, DL., “Introduction: Drug Diversion and Counterfeiting”, Journal of Pharmacy Practice 19 (2006) p. 135.
Lewis, K., “China” s counterfeit medicine trade booming”, CMAJ 10 November 2009, www.cmaj.ca, Accessed Oct 2010.
Lon, CT., R. Tsuyuoka, S. Phanouvong, N. Nivanna, D. Socheat, C. Sokhan, N. Blum, EM. Christophel, A. Smine, “Counterfeit and substandard antimalarial drugs in Cambodia”, Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (2006) pp. 1019-1024.
10.1016/j.trstmh.2006.01.003 :Mac, TL., J-M. Gaulierb, VT. Lec, AN Vuc, P-M Preux, V Ratsimbazafya, “Quality of antiepileptic drugs in Vietnam”, Epilepsy Research 80 (2008) pp; 77-82.
McGinnis, M., “Matrix of Medicine Quality Reports Affecting USAID-assisted Countries” (Maryland: USP PQM, 2010).
Newton, P., S. Proux, M. Green, F. Smithuis, J. Rozendaal, S Prakongpan, K. Chotivanich, M. Mayxay, S. Loareesuwan, J. Farrar, F Nosten, NJ. White, “Fake artesunate in Southeast Asia”, The Lancet 357 (2001) pp. 1948-9.
Newton PN., FM. Ferna’ndez, A. Plancon, DC. Mildenhall, MD. Green, et al. “A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia”, PLoS Med 5/2: e32. (2008).
Newton PN., SJ. Lee, C. Goodman, FM. Fernández, S. Yeung, S. Phanouvong, H. Kaur, AA. Amin, CJM. Whitty, go. Kokwaro, N. Lindegårdh, P. Lukulay, LJ. White, NPJ. Day, MD. Green, NJ. White (2001). Guidelines for field surveys of the quality of medicines: a proposal. PLoS Medicine 6 (3), e1000052.
Phanouvong S., N. Blum, A. Smine. Guidelines for Sampling of Antimalarial Drug Samples in the USP DQI Antimalarial Drug Quality Monitoring Project in Mekong Subregion Countries (Rockville: USP DQI, 2004).
Phyo AP., S. Nkhoma, K. Stepniewska, EA. Ashley, S. Nair, R. McGready, C. ler Moo, S. Al-Saai, AM. Dondorp, KM. Lwin, P. Singhasivanon, NP. Day, NJ. White, TJ. Anderson, F. Nosten. “Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study”. Lancet 379 (2012) pp. 1960-6.
Ratanawijitrasin S. and E. Wondemagegnehu, “Effective Drug Regulation: A Multi-country Study” (Geneva: World Health Organization, 2002).
Ratanawijitrasin S., “System of Pharmacy Services”, Proceedings, Conference on Health Insurance Systems in Thailand. (Bangkok, 2003).
Rozendaal J., “Ministry of Health and Asian Development Bank Intensified Communicable Diseases Control Project”, The Lancet 357 (17 March 2001).
Sengaloundeth S, Green MD, Fernández FM, Manolin O, Phommavong K, Insixiengmay V, Hampton CY, Nyadong L, Mildenhall DC, Hostetler D, Khounsaknalath L, Vongsack L, Phompida S, Vanisaveth V, Syhakhang L, Newton PN (2009) “A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR-implications for therapeutic failure and drug resistance”. Mal J 8, 172.
Shakoor, O., RB. Taylor, RH. Behrens, “Assessment of the incidence of substandard drugs in developing countries”, Trop Med Intl Health 2/9 (1997) pp. 839-45
10.1046/j.1365-3156.1997.d01-403.x :Sovan, N. and C. Yin, “Bad medicine floods countryside”, The Phnom Penh Post, 25 July 2008, www.phnompenhpost.com, Accessed Jul 2010.
The Kingdom of Cambodia, Law on the Management of Pharmaceuticals (1996).
The Kingdom of Thailand, Drug Act BE 2510 (1967).
The Lao People’s Democratic Republic, Law on Drugs and Medical Products (2000)
The National Assembly of the Socialist Republic of Vietnam, Pharmaceutical Law (2005).
The People” s Republic of China, Drug Administration Law (2001).
U.S. Pharmacopeia Drug Quality and Information Program, “A Review of Drug Quality in Asia with Focus on Anti-Infectives” (2004).
U.S. Pharmacopeia Promoting the Quality of Medicines Program. “Guidance for Acting on Evidence-Based Data and Information on Counterfeits and Substandard Medicines to Take Appropriate Enforcement Action”, Working document (2010).
U.S. Pharmacopeia Drug Quality and Information Program, “Medicine quality monitoring program in the Mekong region” (2009).
Wondemagegnehu, E., “Counterfeit and Substandard Drugs in Myanmar and Viet Nam: Report of a study carried out in cooperation with the Governments of Myanmar and Viet Nam” (Geneva: World Health Organization, 1999).
World Health Organization. “Guidelines for the Development of Measures to Combat Counterfeit Drugs.” (Geneva: WHO, 1999).
World Health Organization. “General information on counterfeit medicines”, http://www.who.int/medicines/services/counterfeit/overview/en/index2.html, Accessed Mar 2011.
World Health Organization. “Medicines: counterfeit medicines”, Fact sheet N°275, http://www.who.int/mediacentre/factsheets/2003/fs275/en/, Accessed Jan 2011.
World Health Organization. “Report of the Workshop to review and plan therapeutic efficacy studies to monitor P. falciparum and P. vivax resistance to anti-malarial drugs in the Greater Mekong Sub-region.” Mandalay, Union of Myanmar September 30th-October 2nd, 2009.
Yang D, Plianbangchang P, Visavaungroi N, Rujivipat S., “Quality of Pharmaceutical Items Available From Drugstores in Phnom Penh, Cambodia”. Southeast Asian, J Trop Med Public Health. 35 (3): 741-7 (2004).
____, “Arrests of illegal abortion clinics and counterfeit drugs manufacturer”, Matichon newspaper, 12 Jan 2011.
____, “Counterfeit expensive drugs seized from drugstore in Dindang area”, Matichon newspaper, 1 Oct 2010.
____, “FDA seizes counterfeit Viagra and pain-killer with codeine in Patpong”, Matichon newspaper, 14 Jan 2011.
____, “Vietnam to reinforce crackdown on fake medicine: official”. Thanh Nien News 22 September 2008, www.thanhniennew.com, Accessed Sep 2010.
Le texte seul est utilisable sous licence Licence OpenEdition Books. Les autres éléments (illustrations, fichiers annexes importés) sont « Tous droits réservés », sauf mention contraire.
Perceptions of Borders and Human Migration
The Human (In)Security of Shan Migrant Workers in Thailand
Ropharat Aphijanyatham
2009
La Monnaie des frontières
Migrations birmanes dans le sud de la Thaïlande, structure des réseaux et internationalisation des frontières
Maxime Boutry et Jacques Ivanoff
2009
Informal and Illegal Movement in the Upper Greater Mekong Subregion
Costs and Benefits of Informal Networks for Goods and People
Lynn Thiesmeyer
2010
L’Asie du Sud-Est dans le « siècle chinois »
Cambodge, Laos et Viêt Nam
Danielle Tan et Caroline Grillot
2014
The State of Medicine Quality in the Mekong Sub-Region
Sauwakon Ratanawijitrasin et Souly Phanouvong
2014